Bilaçeroğlu S, Cağirici U, Perim K, Ozacar R
Dept of Thoracic Medicine, Izmir Chest Diseases and Surgery Training Hospital, Turkey.
Monaldi Arch Chest Dis. 1998 Feb;53(1):14-22.
This study was carried out in the pulmonary department of a referral training hospital for thoracic medicine and surgery, with the aim of assessing the effects of pH and glucose level of a pleural effusion (PE) on survival and the response to pleurodesis (PD) with Corynebacterium parvum. A prospective study was carried out in 204 patients with recurrent, symptomatic PEs (73 benign, 131 malignant). Fifty eight per cent of 204 PEs had low pH (< 7.20; 7.01 +/- 0.14) nd glucose levels (< 60 mg.dL-1; 36 +/- 14 mg.dL-1), whereas the remaining 42% had higher pH (> or = 7.20; 7.36 +/- 0.07 and glucose levels (> or = 60 mg.dL-1; 79 +/- 16 mg.dL-1). PD was attempted twice with 7 mg of C. parvum injected through chest tube in all patients, who were then followed up for the outcome of PD and for survival from the time of PD until death or the closure of the study (August 1996). Of 204 cases, 201 were evaluable for survival and outcome of PD. In 91% of the low-and 82% of the high-pH/glucose benign PEs, complete PD was achieved while the corresponding values for the malignant PEs were 79% and 87%, respectively (p > 0.05). Six per cent of low-and 8% of high-pH benign PEs, and 13% of low- and 9% of high-pH malignant PEs were palliated with partial PD. Failures were 3% and 10% in the low- versus high-pH benign groups, and 8% and 4% in the low- versus high-pH malignancies, respectively. All 201 cases maintained the immediate post-PD outcome throughout the follow-up. Average survival was 21.8 months in high-pH benign PEs versus 21.1 months in low-pH benign PEs, and 9.9 versus 8.7 months, in high- and low-pH malignant PEs, respectively (p > 0.05). We deduce that, regarding survival and the response to pleurodesis with Corynebacterium parvum, there is no significant difference between low- and high-pH/glucose pleural effusions in malignant, or benign cases.
本研究在一家胸科医学与外科转诊培训医院的肺病科开展,旨在评估胸腔积液(PE)的pH值和葡萄糖水平对生存以及对微小棒状杆菌胸膜固定术(PD)反应的影响。对204例复发性、有症状的胸腔积液患者(73例良性,131例恶性)进行了一项前瞻性研究。204例胸腔积液中,58%的pH值较低(<7.20;7.01±0.14)且葡萄糖水平较低(<60mg.dL-1;36±14mg.dL-1),而其余42%的pH值较高(≥7.20;7.36±0.07)且葡萄糖水平较高(≥60mg.dL-1;79±16mg.dL-1)。所有患者均通过胸管注射7mg微小棒状杆菌进行两次胸膜固定术尝试,随后对胸膜固定术的结果以及从胸膜固定术时起至死亡或研究结束(1996年8月)的生存情况进行随访。204例病例中,201例可评估生存情况和胸膜固定术结果。在低pH/葡萄糖水平的良性胸腔积液中,91%实现了完全胸膜固定术,高pH/葡萄糖水平的良性胸腔积液中这一比例为82%,而恶性胸腔积液的相应比例分别为 79%和87%(p>0.05)。低pH良性胸腔积液中有6%、高pH良性胸腔积液中有8%,低pH恶性胸腔积液中有13%、高pH恶性胸腔积液中有9%通过部分胸膜固定术得到缓解。低pH与高pH良性组的失败率分别为3%和10%,低pH与高pH恶性组的失败率分别为8%和4%。所有201例病例在整个随访期间均维持胸膜固定术后的即时结果。高pH良性胸腔积液的平均生存期为21.8个月,低pH良性胸腔积液为21.1个月,高pH与低pH恶性胸腔积液的平均生存期分别为9.9个月和8.7个月(p>0.05)。我们推断,就生存情况以及对微小棒状杆菌胸膜固定术的反应而言,恶性或良性病例中低pH/葡萄糖水平与高pH/葡萄糖水平胸腔积液之间无显著差异。